Literature DB >> 24460191

Diverse effects of LPA receptors on cell motile activities of cancer cells.

Toshifumi Tsujiuchi1, Miku Hirane, Yan Dong, Nobuyuki Fukushima.   

Abstract

Lysophosphatidic acid (LPA) is a bioactive lipid that interacts with G protein-coupled transmembrane LPA receptors (LPA1 to LPA6). LPA mediates a variety of cellular responses in normal cells, including cell growth, motility, differentiation, morphogenesis, and prevention from apoptosis. Furthermore, LPA signaling via LPA receptors is involved in the pathogenesis of several diseases, including cancer. Cell motility is one of the important properties during the progression of cancer cells. In recent studies, it has been demonstrated that LPA receptors have the diverse effects in the cell motile activities of cancer cells, depending on the cell types involved. In this review, we provide the current knowledge for the biological roles of LPA receptors in the cell motile activities of cancer cells.

Entities:  

Keywords:  Cancer cells; LPA; LPA receptor; cell motility

Mesh:

Substances:

Year:  2014        PMID: 24460191     DOI: 10.3109/10799893.2013.876042

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  7 in total

Review 1.  Current Understanding of the Pathways Involved in Adult Stem and Progenitor Cell Migration for Tissue Homeostasis and Repair.

Authors:  Polina Goichberg
Journal:  Stem Cell Rev Rep       Date:  2016-08       Impact factor: 5.739

2.  Lysophosphatidic acid receptor-5 negatively regulates cell motile and invasive activities of human sarcoma cell lines.

Authors:  Yan Dong; Miku Hirane; Mutsumi Araki; Nobuyuki Fukushima; Kanya Honoki; Toshifumi Tsujiuchi
Journal:  Mol Cell Biochem       Date:  2014-03-28       Impact factor: 3.396

3.  LPA signaling through LPA receptors regulates cellular functions of endothelial cells treated with anticancer drugs.

Authors:  Shiori Mori; Mutsumi Araki; Shuhei Ishii; Miku Hirane; Kaori Fukushima; Ayaka Tomimatsu; Kaede Takahashi; Nobuyuki Fukushima; Toshifumi Tsujiuchi
Journal:  Mol Cell Biochem       Date:  2015-06-27       Impact factor: 3.396

4.  Small lipidated anti-obesity compounds derived from neuromedin U.

Authors:  Ewa D Micewicz; Omar S O Bahattab; Gary B Willars; Alan J Waring; Mohamad Navab; Julian P Whitelegge; William H McBride; Piotr Ruchala
Journal:  Eur J Med Chem       Date:  2015-07-14       Impact factor: 6.514

5.  Activity and clinical relevance of autotaxin and lysophosphatidic acid pathways in high-grade serous carcinoma.

Authors:  Hadil Onallah; Liora Jacobs Catane; Claes G Tropé; Thea E Hetland Falkenthal; Reuven Reich; Ben Davidson
Journal:  Virchows Arch       Date:  2018-07-21       Impact factor: 4.064

Review 6.  G-Protein-Coupled Lysophosphatidic Acid Receptors and Their Regulation of AKT Signaling.

Authors:  Anjum Riaz; Ying Huang; Staffan Johansson
Journal:  Int J Mol Sci       Date:  2016-02-05       Impact factor: 5.923

Review 7.  Deregulation of Lipid Metabolism: The Critical Factors in Ovarian Cancer.

Authors:  Zhaodong Ji; Yan Shen; Xu Feng; Yue Kong; Yang Shao; Jiao Meng; Xiaofei Zhang; Gong Yang
Journal:  Front Oncol       Date:  2020-10-19       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.